Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by jayjay2020on Jul 19, 2019 10:23am
99 Views
Post# 29939437

RE:RE:RE:RE:RE:Wow!!

RE:RE:RE:RE:RE:Wow!!
gottahunch wrote: Morning everyone,
Invstigator, good questions and I know you like to get discussions going! I’ll bite on this and present a few arguments and comments for each side.
 
First off, I do not think Aphria is foolish enough to do anything that would appear like more inside deals. That is why Vic is gone and Irwin is supposed to be cleaning up shop. Any whiff of BS going on will not be tolerated by the markets.
 
Other random thoughts/comments:
  • ACT II & Aphria both raised money in April. Coincidence? Not sure but coincidences rarely happen in business. I suspect Aphria thought DD would be approved early than today (hopefully LOL). Counter argument to this is Aphria just needs money for operations/Germany ramp up.
  • Irwin’s 90 day plan and the fact that he’s not permanent CEO. Could the 90 day plan include a US play and him heading up ACT II? Then we get a new CEO?
  • Trade mark filings for Good Supply/RIFF in the US (someone mentioned Broken Coast too but I did not look that up). If you read through the filings they mention products like topical CBD. RIFF was trade marked by LHS and given up as per jayjay’s post and Aphria picked it up. The counter argument to this is companies file for trade marks all the time, it could be nothing.
  • Ex-whole foods CEO on board. Is it not possible that CBD products through Good Supply/RIFF will be available through WF?
  • CPG comes up in Irwin’s interviews as what he sees Aphria as. It’s also in the Nasdaq listing of ACT II in their description of the company.
 
Would be great to hear everyone’s thoughts on this.

INVSTIGAT0R wrote: I'd like to know why any of you are speculating ACT II in a positive manner. It may or may not be at all related to Aphria and if it is? It's separate, which means if it were to become a part of Aphria, shareholders of Aphria would be the ones paying for it. Is Irwin going to let ACT II become part of Aphria at cost? Or will it just be another shell type entity flipped to Aphria for more money yet again? Someone explain how ACT II is at all beneficial please. It's not part of Aphria and the 300k is not our money. If ACT II isn't at all part of the Aphria plan then what the hell is Irwin doing with his time?


Act II has cash on hand.  They need to use it.  They have no operations at the present time. Just money in the bank.  Act II was setup to acquire something.  If ACT II acquires TRST .  TRST becomes a Nasdaq listed compnay owned by ACT II.  There is no TSX violation as TRST would just remove its listing on the TSX after the acquisition.  No big deal.  TRST has more issues then a delisting to worry about.  TRST/ ACT II becomes a US MSO bringing in LHS and others under its umbrella.  How does APHA benefit from this?  The direction needs to be clear by Irwin right from the start.  He needs to make it clear that this is not an inside deal or shell game.  APHA/ACT II can do sort a WEED/ ACREAGE type deal where shares are exchanged when legalization happens. If the value is reasonable where APHA is paying a reasonable amount of money  at future date for ACT II upon US legalization then what has essentially happened is APHA has used ACT II's current cash to acquire TRST. ACT II gets a return in APHA shares at a later date.  It is an interesting scenerio if done right.  However, this is pure speculation on my part.  

Bullboard Posts